vs

Side-by-side financial comparison of Bank7 Corp. (BSVN) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $24.1M, roughly 1.7× Bank7 Corp.). Bank7 Corp. runs the higher net margin — 44.7% vs -17.2%, a 62.0% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -0.1%). Bank7 Corp. produced more free cash flow last quarter ($41.4M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 0.2%).

Bank7 Corp. is a U.S.-headquartered financial holding company that operates the full-service community bank Bank7. It provides a range of commercial and consumer banking products including deposit accounts, small business loans, commercial real estate financing, and personal lending solutions, with its primary market footprint covering Oklahoma, Texas, and Kansas, targeting small to medium-sized enterprises and retail customers.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

BSVN vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.7× larger
STIM
$41.8M
$24.1M
BSVN
Growing faster (revenue YoY)
STIM
STIM
+85.9% gap
STIM
85.7%
-0.1%
BSVN
Higher net margin
BSVN
BSVN
62.0% more per $
BSVN
44.7%
-17.2%
STIM
More free cash flow
BSVN
BSVN
$40.7M more FCF
BSVN
$41.4M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
0.2%
BSVN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BSVN
BSVN
STIM
STIM
Revenue
$24.1M
$41.8M
Net Profit
$10.8M
$-7.2M
Gross Margin
52.0%
Operating Margin
58.7%
-12.1%
Net Margin
44.7%
-17.2%
Revenue YoY
-0.1%
85.7%
Net Profit YoY
-2.9%
43.2%
EPS (diluted)
$1.13
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BSVN
BSVN
STIM
STIM
Q4 25
$24.1M
$41.8M
Q3 25
$25.2M
$37.3M
Q2 25
$24.4M
$38.1M
Q1 25
$22.6M
$32.0M
Q4 24
$24.1M
$22.5M
Q3 24
$24.9M
$18.5M
Q2 24
$24.4M
$16.4M
Q1 24
$24.0M
$17.4M
Net Profit
BSVN
BSVN
STIM
STIM
Q4 25
$10.8M
$-7.2M
Q3 25
$10.8M
$-9.0M
Q2 25
$11.1M
$-10.1M
Q1 25
$10.3M
$-12.7M
Q4 24
$11.1M
$-12.7M
Q3 24
$11.8M
$-13.3M
Q2 24
$11.5M
$-9.8M
Q1 24
$11.3M
$-7.9M
Gross Margin
BSVN
BSVN
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
BSVN
BSVN
STIM
STIM
Q4 25
58.7%
-12.1%
Q3 25
56.2%
-19.6%
Q2 25
60.2%
-21.1%
Q1 25
60.7%
-34.4%
Q4 24
61.0%
-51.0%
Q3 24
62.2%
-41.7%
Q2 24
62.5%
-51.7%
Q1 24
62.0%
-39.4%
Net Margin
BSVN
BSVN
STIM
STIM
Q4 25
44.7%
-17.2%
Q3 25
43.0%
-24.3%
Q2 25
45.4%
-26.6%
Q1 25
45.7%
-39.6%
Q4 24
46.0%
-56.4%
Q3 24
47.3%
-72.0%
Q2 24
47.2%
-59.8%
Q1 24
47.0%
-45.2%
EPS (diluted)
BSVN
BSVN
STIM
STIM
Q4 25
$1.13
$-0.10
Q3 25
$1.13
$-0.13
Q2 25
$1.16
$-0.15
Q1 25
$1.08
$-0.21
Q4 24
$1.16
$-0.34
Q3 24
$1.24
$-0.44
Q2 24
$1.23
$-0.33
Q1 24
$1.21
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BSVN
BSVN
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$251.0M
$22.4M
Total Assets
$2.0B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BSVN
BSVN
STIM
STIM
Q4 25
$28.1M
Q3 25
$28.0M
Q2 25
$11.0M
Q1 25
$20.2M
Q4 24
$18.5M
Q3 24
$20.9M
Q2 24
$42.6M
Q1 24
$47.7M
Total Debt
BSVN
BSVN
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
BSVN
BSVN
STIM
STIM
Q4 25
$251.0M
$22.4M
Q3 25
$241.7M
$27.4M
Q2 25
$231.9M
$27.1M
Q1 25
$221.7M
$35.5M
Q4 24
$213.2M
$27.7M
Q3 24
$204.2M
$9.4M
Q2 24
$190.8M
$19.4M
Q1 24
$180.4M
$27.7M
Total Assets
BSVN
BSVN
STIM
STIM
Q4 25
$2.0B
$141.6M
Q3 25
$1.9B
$145.5M
Q2 25
$1.8B
$134.7M
Q1 25
$1.8B
$142.0M
Q4 24
$1.7B
$140.9M
Q3 24
$1.7B
Q2 24
$1.7B
$96.8M
Q1 24
$1.8B
$103.8M
Debt / Equity
BSVN
BSVN
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BSVN
BSVN
STIM
STIM
Operating Cash FlowLast quarter
$46.1M
$908.0K
Free Cash FlowOCF − Capex
$41.4M
$692.0K
FCF MarginFCF / Revenue
171.7%
1.7%
Capex IntensityCapex / Revenue
19.7%
0.5%
Cash ConversionOCF / Net Profit
4.28×
TTM Free Cash FlowTrailing 4 quarters
$74.8M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BSVN
BSVN
STIM
STIM
Q4 25
$46.1M
$908.0K
Q3 25
$16.6M
$-785.0K
Q2 25
$9.4M
$-3.5M
Q1 25
$11.0M
$-17.0M
Q4 24
$55.0M
$-8.6M
Q3 24
$13.4M
$-5.4M
Q2 24
$8.1M
$-5.0M
Q1 24
$20.4M
$-12.0M
Free Cash Flow
BSVN
BSVN
STIM
STIM
Q4 25
$41.4M
$692.0K
Q3 25
$16.4M
$-899.0K
Q2 25
$8.8M
$-3.8M
Q1 25
$8.2M
$-17.2M
Q4 24
$50.8M
$-8.7M
Q3 24
$12.7M
$-5.8M
Q2 24
$6.5M
$-5.6M
Q1 24
$19.8M
$-12.4M
FCF Margin
BSVN
BSVN
STIM
STIM
Q4 25
171.7%
1.7%
Q3 25
65.0%
-2.4%
Q2 25
36.1%
-9.9%
Q1 25
36.3%
-53.8%
Q4 24
210.6%
-38.6%
Q3 24
51.2%
-31.3%
Q2 24
26.8%
-34.0%
Q1 24
82.3%
-71.1%
Capex Intensity
BSVN
BSVN
STIM
STIM
Q4 25
19.7%
0.5%
Q3 25
0.8%
0.3%
Q2 25
2.6%
0.7%
Q1 25
12.4%
0.7%
Q4 24
17.4%
0.4%
Q3 24
2.5%
2.1%
Q2 24
6.6%
3.7%
Q1 24
2.8%
2.2%
Cash Conversion
BSVN
BSVN
STIM
STIM
Q4 25
4.28×
Q3 25
1.53×
Q2 25
0.85×
Q1 25
1.06×
Q4 24
4.96×
Q3 24
1.13×
Q2 24
0.71×
Q1 24
1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons